Ashley Freeman, PA
Physician Assistant · Ronceverte, WVNPI 1700439387
Payments from drug & device makers
Across 169 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$710
- Novo Nordisk$489
- AstraZeneca$260
- GSK$161
- Lilly USA, LLC$130
- Bayer$89
- plus $827 from 22 others
What the payments were for
- Food & beverage$2,667100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 51 | $710 |
| Novo Nordisk | 32 | $489 |
| AstraZeneca(2 entities) | 13 | $260 |
| GSK | 8 | $161 |
| Lilly USA, LLC | 6 | $130 |
| Bayer | 5 | $89 |
| Sunovion Pharmaceuticals Inc. | 5 | $81 |
| Amgen | 6 | $80 |
| Argenx US, Inc. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $69 |
| Biohaven Pharmaceuticals, Inc. | 4 | $67 |
| Boehringer Ingelheim | 5 | $62 |
| Pfizer | 3 | $56 |
| Amarin Pharma, Inc. | 4 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Johnson & Johnson(2 entities) | 2 | $28 |
| AbbVie | 2 | $27 |
| Vifor Pharma, Inc. | 2 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Corcept Therapeutics | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
How this compares
$2,667 in reported general payments places this provider in the 85th percentile of 833 physician assistant providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 31 | $171 |
| Doxycycline Hyclate | 23 | $159 |
| Cefdinir | 18 | $144 |
| Prednisone | 21 | $38 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Ronceverte
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Tasha ElswickWinfield$14K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Erik AndersonSouth Charleston$11K
- Catherine EnsingerParkersburg$11K
- Gregory PorterSouth Charleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.